(Q62801538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

N Simonney

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

G Dewulf

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M C Gutierrez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

E Vicaut

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

C Boutron

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Leportier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Lafaurie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S Abgrall

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

D Sereni

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

B Autran

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

G Carcelain

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A Bourgarit

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

P H Lagrange

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

21 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

453-461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Immune reconstitution inflammatory syndrome in HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Immune restoration disease: a consequence of dysregulated immune responses after HAART.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Immunologic diagnosis of tuberculosis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Preliminary evaluation of a Mycobacterium tuberculosis lipooligosaccharide (LOS) antigen in the serological diagnosis of tuberculosis in HIV seropositive and seronegative patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Analysis of the immunological humoral response to Mycobacterium tuberculosis glycolipid antigens (DAT, PGLTb1) for diagnosis of tuberculosis in HIV-seropositive and -seronegative patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

B-cell immune responses in HIV positive and HIV negative patients with tuberculosis evaluated with an ELISA using a glycolipid antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Is there a relationship between Mycobacterium tuberculosis strain type and TB paradoxical reaction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Use of the INNO-LiPA-MYCOBACTERIA assay (version 2) for identification of Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Assessment of an optimized mycobacterial interspersed repetitive- unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Evaluation of Mycobacterium tuberculosis--specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guérin. Heterogeneity, structure, and role in the regulation of cytokine secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Kinectics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Evaluation of a novel 2,3-diacyl-trehalose-2'-sulphate (SL-IV) antigen for case finding and diagnosis of leprosy and tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Antigenicity and specificity of selected glycolipid fractions from Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Circulating immune complexes in human tuberculosis sera: demonstration of specific antibodies against Mycobacterium tuberculosis glycolipid (DAT, PGLTb1, LOS) antigens in isolated circulating immune complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Specificity of antibodies and tuberculin response after occupational exposure to tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Immunologic diagnosis of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

The continuing challenges of leprosy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Epidemiological characteristics of leprosy reactions: 15 years experience from north India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

Infrequent detection of lipoarabinomannan antibodies in human immunodeficiency virus-associated mycobacterial disease. Swiss HIV Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Antibody-based enzyme-linked immunosorbent assay for determination of anti-PGL-I specific circulating immune complex in leprosy patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2008.01.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2008.01.006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495539%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference